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Intramembrane proteolysis by γ-secretases plays major roles in disease pathology and cellular 
signalling, yet the dynamics of these enzyme complexes and how they recognize substrates remains 
poorly understood. New work in The EMBO Journal utilizes photoaffinity crosslinking to map APP 
interactions to different γ-secretase subunits, suggesting a succession of recruitment and 
engagement steps that lead up to substrate cleavage. 
 γ-Secretases are fascinating multimeric intramembrane protease complexes involved in a wide 
spectrum of biological activities (Jurisch-Yaksi et al, 2013). They cleave many and very different 
substrates in the membrane using an intriguing multiple turnover mechanism, which releases 
proteolytic fragments at both sides of the cell membrane and possibly also hydrophobic peptides into 
the membrane. Many of this newly generated intracellular fragments exert (or are supposed to exert) 
signalling functions (Jurisch-Yaksi et al, 2013), while some of the extracellular fragments, like the Aβ 
fragment generated from the Alzheimer’s disease-related amyloid precursor protein (APP),  play a 
central role in disease pathology (De Strooper & Chávez Gutiérrez, 2015). γ-secretase complexes 
consist of presenilin (PSEN), nicastrin (NCT), presenilin-enhancer 2 (PEN2) and anterior pharynx 
defective 1 (APH1) subunits, and perform endoproteolytic, carboxypeptidase-like, and even 
aminopeptidase activities (De Strooper & Chávez Gutiérrez, 2015). Details of the interaction of these 
different subunits have recently been revealed in atomic structures obtained by cryo-electron 
microscopy (Bai et al, 2015a, 2015b). However, to unravel crucial questions such as the mechanisms 
that underlie the different proteolytic activities, the dynamics of the complexes, or the way substrates 
are recognized, further work is needed 
 While their relaxed specificity would suggest that γ-secretase complexes indiscriminately cut 
type I integral membrane proteins after removal of their ectodomain, kinetic data indicate that γ-
secretases do distinguish between substrates (Chávez-Gutiérrez et al, 2012). Furthermore, the 
strength of the interaction between enzyme and the substrate transmembrane domain (TMDs) may 
drive endo-proteolysis, as shown for the case of Notch receptor (Bolduc et al, 2016). Finally, differential 
subcellular localisation of γ-secretases and their targets also adds substrate specificity to each complex 
(Sannerud et al, 2016).  
How exactly γ-secretases recognize their substrates at the molecular level remains a largely 
unaddressed question. Answering it could have huge implications for the development of safer drugs 
for Alzheimer’s disease and certain cancers, since it could allow the development of selective inhibitors 
that interfere with the processing of specific (subsets of) substrates while sparing the processing of 
others. Obviously, this would constitute a much safer approach than the clinically tested (and failed) 
broad spectrum γ-secretase inhibitors (De Strooper & Chávez Gutiérrez, 2015).   
 Writing in this issue of The EMBO Journal, Fukumori and Steiner (2016) describe an innovative 
and extremely labour-intensive approach to investigate how one particular substrate interacts with 
the γ-secretase complex at the level of the single amino acid residue. In a real tour de force, they 
delineated a substrate-binding “exosite” in the complex, from which the substrate is then transferred 
to a “docking site” close to (or even overlapping with) the catalytic site. These translocations imply 
significant conformational changes in the complex.       
 Fukumori and Steiner incorporated the photo-activatable amino acid analogue p-
benzoylphenylalanine (Bpa) at 68 different positions into recombinant APP-CTF, a 99 amino acid 
carboxyterminal fragment of the well-studied γ-secretase substrate APP. Each of the resulting 68 
substrates was incubated with solubilized γ-secretase preparations, followed by UV light-dependent 
activation of the Bpa moiety that cross-links the substrate to the complex only if Bpa was less than 3Å 
distant from potential interacting residues; this can be probed by the resulting shift in migration of the 
cross-linked protein in SDS-Page. These experiments revealed a series of interactions between the 
APP-CTF substrate and the amino-terminal fragment of the catalytic presenilin subunit of γ-secretase 
(PSEN-NTF). In contrast, the carboxyterminal fragment of presenilin (PSEN-CTF) appeared to engage in 
close interactions only with amino acid residues at the membrane-cytosol border of the substrate. 
Interestingly, a recent atomic model of γ-secretase in complex with an inhibitor shows how the 
cytosolic end of PSEN-CTF is inserted into the PSEN-NTF fold, bringing the catalytic Asp-385 residue at 
hydrogen-bonding distance of its cognate Asp-257 site within PSEN-NTF (Figure 1) (Bai et al, 2015b). 
 All these data taken together indicate that the substrate is embraced by the PSEN-NTF during 
catalysis, except for its carboxyterminal-terminal end that contacts PSEN-CTF in a hydrophilic 
environment. Thus, it is tempting to speculate that a hydrophobic interaction with PSEN-NTF holds the 
substrate and aligns it for catalysis by exposing its cytosolic end to the hydrophilic environment where 
the catalytic aspartate in the PSEN-CTF transmembrane domain (TM7) lies in waiting. However, the 
photo-crosslinking experiments not only revealed substrate interactions with the catalytic presenilin 
subunit, but also uncovered interactions with the PEN2 and nicastrin subunits. Nicastrin contacts 
mainly residues close to the substrate amino-terminus, while PEN2 cross-links to regions flanking the 
APP transmembrane domain. The nicastrin ectodomain has been suggested to bind the free amino-
terminus of substrates (Shah et al, 2005), but this model has been debated (Chavez-Gutierrez et al, 
2008; Zhao et al, 2010); more recent data point to a passive role for the nicastrin ectodomain in 
substrate recruitment by obstructing the entrance of substrates with bulky ectodomains (Bolduc et al, 
2016). Intriguingly, both scenarios imply close proximity between the amino-terminal region of 
substrates and the nicastrin ectodomain. Whether this influences substrate specificity and/or catalysis 
remains to be addressed.  
It is highly notable that the observed contact patterns for PEN2 seem to indicate substrate binding to 
the unstructured, flexible N- and C-termini of PEN2, rather than interactions involving the PEN2 
transmembrane domains. PEN2 transmembrane domains are located at opposite from the proposed 
substrate entrance gate (likely PSEN TM2/TM6), while the flexible PEN2 amino-terminus lies much 
closer (less than 12Å in distance) to the cytosolic end of the PSEN transmembrane domain 6 (active 
site) (Figure1). Moreover, experimental elongation of the PEN2 amino-terminus was found to affect 
substrate processing as observed by altered Aβ42:Aβ40 ratios (Isoo et al, 2007). Based on the new 
results of Fukumori and Steiner, one may speculate that PEN2 amino-terminal elongation might affect 
the architecture of the exosite and alter substrate translocation to the active site to favour the 
production of Aβ42. 
 Finally, Fukumori and Steiner (2016) also performed highly interesting and more dynamic 
pulse-chase experiments, in which substrate binding and crosslinking to the enzyme takes place at 4°C 
and is followed by incubation at 37°C to activate γ-secretase proteolysis. This showed that substrates 
bound to the exosite do not get cleaved, while substrates bound to the docking/catalytic site are 
processed. The authors relate this to the progressive transfer of substrate from exosite to catalytic 
site, and conclude that substrates first need to be transferred out of the exosite to subsequently be 
cleaved. Consistently, previous reports have shown important conformational changes in γ-secretase 
upon binding of substrate (Uemura et al, 2010) or inhibitor (Elad et al, 2015; Li et al, 2014).  
 A better understanding of how substrates interact with γ-secretase may help in the design of 
strategies to selectively inhibit, activate or modulate γ-secretase-mediated cleavage(s) of particular 
substrates. The findings of Fukumori and Steiner (2106) make a step forward into that direction. An 
important concept supported by the current work is that beyond the recent breakthrough studies on 
the atomic structure of the enzyme (Bai et al, 2015a, 2015b), different conformations of the complex 
will probably have to be elucidated to obtain comprehensive understanding of the functioning of these 
enigmatic complexes. A new era of drug development will start once further functional-structural 
studies (such as those presented here by Fukumori and Steiner) combined with profound structural 
analysis will have brought dynamics to the structures of these complex intramembrane proteolysis 
machines, leading to more effective and safer drugs in the fight against Alzheimer’s disease and cancer.  
 
Figure legend 
Figure 1:  Lateral view of the membrane core of the γ-secretase complex (PDB entry: 5FN3) with PSEN1-
NTF and -CTF coloured in orange and green, respectively, and catalytic Asp residues displayed as rod 
models. Additional subunits PSEN2, APH1 and NCT are shown in light green, pale brown and pale 
yellow, respectively. An arrow indicates the putative substrate entrance. 
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